Table 1.
Variable | Overall | Group 1 | Group 2 | P value |
(n = 25) | (n = 12) | (n = 13) | ||
Age (yr)1 | 45.08 ± 11.74 | 46.69 ± 12.69 | 43.33 ± 10.88 | 0.48 |
Sex | ||||
Male | 15 (60.0) | 9 (75.0) | 6 (46.2) | 0.23 |
Female | 10 (40.0) | 3 (25.0) | 7 (53.9) | |
Primary | ||||
Protein C deficiency | 2 (8.0) | 1 (8.3) | 1 (7.7) | 1.00 |
Protein S deficiency | 2 (8.0) | 0 (0.0) | 2 (15.4) | 0.48 |
Antithrombin IIIdeficiency | 2 (8.0) | 1 (8.3) | 1 (7.7) | 1.00 |
Factor V Leiden disorder | 1 (4.0) | 1 (8.3) | 0 (0.0) | 0.48 |
Antiphospholipid syndrome | 2 (8.0) | 1 (8.3) | 1 (7.7) | 1.00 |
No thrombophilia | 16 (64.0) | 8 (66.7) | 8 (61.5) | 1.00 |
Secondary | ||||
History of splenectomy | 6 (24.0) | 4 (33.3) | 2 (15.4) | 0.38 |
Other earlier abdominal surgery | 6 (24.0) | 4 (33.3) | 2 (15.4) | 0.38 |
Prior DVT/PE | 3 (12.0) | 1 (8.3) | 2 (15.4) | 1.00 |
Cerebral infarction | 4 (16.0) | 3 (25.0) | 1 (7.7) | 0.32 |
Pancreatitis | 2 (8.0) | 1 (8.3) | 1 (7.7) | 1.00 |
Inflammatory bowel disease | 1 (4.0) | 1 (8.3) | 0 (0.0) | 0.48 |
Oral contraceptive use | 3 (12.0) | 1 (8.3) | 2 (15.4) | 1.00 |
Pregnancy | 3 (12.0) | 2 (16.7) | 1 (7.7) | 0.59 |
Alcohol abuse | 4 (16.0) | 2 (16.7) | 2 (15.4) | 1.00 |
Malignancy | 3 (12.0) | 1 (8.3) | 2 (15.4) | 1.00 |
Cirrhosis/portal hypertension | 8 (32.0) | 3 (25.0) | 5 (38.5) | 0.67 |
Bilharzial cirrhosis | 2 (8.0) | 1 (8.3) | 1 (7.7) | 1.00 |
Non-bilharzial cirrhosis | 6 (24.0) | 2 (16.7) | 4 (30.8) | 0.65 |
Diabetes mellitus | 1 (4.0) | 1 (8.3) | 0 (0.0) | 0.48 |
Hypertension | 1 (4.0) | 0 (0.0) | 1 (7.7) | 1.00 |
Analysis was performed by t test or Fisher’s exact test. DVT: Deep vein thrombosis; PE: Pulmonary embolism.